Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

STLN vs PIII: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PIII Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–1 Matrix Metrics)

PIII Overall Winner 6-Pillar Tally: STLN 0 – 5 PIII (1 Tie) Matrix Metrics: STLN 1 – 6 PIII

As of Nov 20, 2026, P3 Health Partners Inc. (PIII) is the stronger overall head-to-head candidate over STLN (STLN) in the Tradestie Institutional Equity Comparison Engine, winning 6–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). STLN carries a Unified Composite Score of 46.6/100 (HOLD) at $3.00 (N/M Forward P/E, N/A operating margin), whereas PIII carries 38.6/100 (SELL) at $1.69 (N/M Forward P/E, -5.2% operating margin).

  • Composite vs. Pillar Nuance: While STLN currently prints a higher short-term Unified Composite Score (46.6/100 HOLD vs. PIII 38.6/100 SELL), PIII captures the overall institutional head-to-head verdict (6–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-5.2% vs. N/A operating margin) and revenue trajectory (+14.8% vs. N/A YoY).
  • Technical & Structure Timing Caution: STLN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.4); meanwhile PIII is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About STLN vs PIII
STLN US Equity
STLN
Institutional Equity
$3.00
-5.66% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.42β · 175% Vol
Unified Composite Score
46.6 / 100 HOLD
Tech 45.0 Fund 46.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.2%), weak momentum, RSI 26
RSI-14: 26.4 · SMA20: $4.93 · SMA50: $5.93
PIII NASDAQ Head-to-Head Winner
P3 Health Partners Inc. Common Stock
Services-Health Services
$1.69
-9.14% 1D
Market Cap $385.5M
TTM Revenue $1.55B
Forward P/E N/M
Beta / 30D Vol -0.87β · 132% Vol
Unified Composite Score
38.6 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 49.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -34.1%), weak momentum, RSI 21
RSI-14: 21.1 · SMA20: $3.28 · SMA50: $4.87

6-Pillar Scorecard Institutional Category Breakdown (STLN 0 – 5 PIII)

Columns: Metric · STLN · PIII
1. Valuation Multiples PIII
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.4x
2. Growth & Scale PIII
Revenue Growth (YoY) N/A +14.8%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A $1.55B
Market Cap N/A $385.5M
3. Profitability & Quality PIII
Gross Margin N/A 9.4%
Operating Margin N/A -5.2%
Net Profit Margin N/A -3.3%
Return on Equity (ROE) N/A -105.8%
4. Balance Sheet & Cash Flow PIII
Cash Generation (TTM) N/A -$85M
Cash Flow Margin N/A -5.5%
Net Cash / Leverage N/A ROE $297M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat PIII
OpEx & R&D Intensity N/A 14.6% of Rev ($227M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: STLN (1) vs PIII (6)
Institutional Metric STLN PIII Criterion Row Edge
Market Capitalization
Scale
N/A $385.5M Larger Scale PIII
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A +14.8% Higher Growth PIII
Operating Margin (TTM)
Profitability
N/A -5.2% Higher Margin PIII
Net Profit Margin
Profitability
N/A -3.3% Higher Margin PIII
Return on Equity (ROE)
Capital Efficiency
N/A -105.8% Higher ROE PIII
52-Week Range Position
Momentum
1% ($3–$7) 1% ($2–$17) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
1.42β · 175% Vol -0.87β · 132% Vol Lower Realized Risk PIII
Unified Institutional Score
Composite Signal
46.6 / 100 (HOLD) 38.6 / 100 (SELL) Higher Composite STLN
Trailing 12M Revenue (USD)
Operating Scale
N/A $1.55B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 9.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$85M ($297M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon STLN +4.66 pp
STLN: -56.58% · PIII: -61.24%
3M Horizon STLN +32.09 pp
STLN: -51.06% · PIII: -83.15%
6M Horizon STLN +41.75 pp
STLN: -41.97% · PIII: -83.72%
1Y Horizon STLN +41.75 pp
STLN: -41.97% · PIII: -83.72%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on STLN vs PIII. Trailing 12-month operating profitability (STLN N/A vs PIII -5.2%) and valuation multiples (STLN N/M vs PIII N/M Forward P/E) are benchmarked directly in Pillar 4 below.

STLN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
PIII ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.55B
Gross Margin9.4%
Op. Margin-5.2%
ROE / Fwd P/E-105.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
STLN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact STLN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PIII UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PIII Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
STLN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
PIII Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $385.5M market capitalization and -5.2% operating margin.
OpEx & R&D Reinvestment 14.6% of Rev ($227M)
90D Engineering Disclosures 0 Published

Investor FAQ STLN vs PIII Key Questions & Quantitative Answers

As of Nov 20, 2026, P3 Health Partners Inc. (PIII) is the stronger overall head-to-head candidate over STLN (STLN) in the Tradestie Institutional Equity Comparison Engine, winning 6–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). STLN carries a Unified Composite Score of 46.6/100 (HOLD) at $3.00 (N/M Forward P/E, N/A operating margin), whereas PIII carries 38.6/100 (SELL) at $1.69 (N/M Forward P/E, -5.2% operating margin). Composite vs. Pillar Nuance: While STLN currently prints a higher short-term Unified Composite Score (46.6/100 HOLD vs. PIII 38.6/100 SELL), PIII captures the overall institutional head-to-head verdict (6–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-5.2% vs. N/A operating margin) and revenue trajectory (+14.8% vs. N/A YoY). Technical & Structure Timing Caution: STLN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.4); meanwhile PIII is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PIII leads the Growth & Scale pillar: STLN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with PIII at +14.8% YoY revenue growth and +0.0% YoY earnings growth on $1.55B TTM revenue (9.4% gross margin, -5.2% operating margin). On trailing 12-month operating scale, STLN generates N/A in USD-normalized revenue versus $1.55B for PIII. In operating R&D and SG&A reinvestment, STLN deploys N/A (0 90-day corporate R&D disclosures) versus 14.6% of Rev ($227M) (0 disclosures) for PIII.

PIII screens cheaper on headline valuation multiples. STLN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PIII trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.4x EV/Revenue (-5.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against STLN (N/A ROE) versus PIII (-105.8% ROE) capital efficiency.

In options market volatility and institutional positioning, STLN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.42β · 175% Vol realized risk). By comparison, PIII carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.87β · 132% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.